Deb Friedman: State commission’s interpretation of antisemitism shows bias

Kaboompics.com

Published: 05-28-2025 12:47 PM

I appreciate the Special Commission on Combatting Antisemitism’s desire to combat antisemitism in Massachusetts, but am troubled by the bias shown by the commission’s noticeable deference to a Zionist-leaning/Israel-promoted interpretation of what constitutes antisemitism. There are many Jews in Massachusetts who are not Zionists, and the assumption that equates Israel and Zionism with Jewish self-identity is itself antisemitic. (Also, some Jews consider themselves Zionists without meaning it politically, i.e., not as followers of nationalist Zionism and its state, Israel.)

According to Kenneth Stern, the International Holocaust Remembrance Alliance (IHRA)’s guidelines to its 2016 antisemitism definition include antisemitism resulting from associating all Jews with the state of Israel, which is different from saying all anti-Zionism is antisemitic. Stern, director of the Bard Center for the Study of Hate, has expressed deep concern over the way the IHRA definition is being used today (https://www.youtube.com/watch?v=wyjYk8bsYT8).

I’ve watched the commission, with not a single pro-Palestinian or anti-Zionist Jew among its members, come very close to fully equating anti-Zionism with antisemitism. A local Jewish leader and a local Jewish columnist have both cautioned, and I agree, antisemitism could well increase rather than decrease if the commission’s bias continues.

Deb Friedman

Easthampton

Yesterday's Most Read Articles

Marine vet gets 24 months of supervised release in stolen valor case, must pay nearly $300K in restitution
Real Estate Transactions: June 20, 2025
My Turn: Angelenos must not let National Guard silence them
Green River Festival brings ‘cultural melting pot’ of music to fairgrounds
Mobile Health Unit helps expand Community Health Center of Franklin County’s services
With a little help from his community: Northfield Mount Hermon teacher fighting rare form of cancer begins clinical trial